IRCSX
Price
$15.56
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
1.3B
MCISX
Price
$21.58
Change
-$0.15 (-0.69%)
Updated
Jun 2 closing price
Net Assets
4.78B
Interact to see
Advertisement

IRCSX vs MCISX

Header iconIRCSX vs MCISX Comparison
Open Charts IRCSX vs MCISXBanner chart's image
IRCSX vs MCISX Comparison Chart in %
View a ticker or compare two or three
VS
IRCSX vs. MCISX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRCSX is a Hold and MCISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MCISX has more cash in the bank: 4.78B vs. IRCSX (1.3B). IRCSX pays higher dividends than MCISX: IRCSX (1.94) vs MCISX (0.89). IRCSX was incepted earlier than MCISX: IRCSX (10 years) vs MCISX (19 years). MCISX (3.49) is less costly to investors than IRCSX (1.33). IRCSX is a more actively managed with annual turnover of: 57.00 vs. MCISX (49.00). MCISX has a lower initial minimum investment than IRCSX: MCISX (2500) vs IRCSX (5000). MCISX annual gain was more profitable for investors over the last year : 26.73 vs. IRCSX (13.80). MCISX (26.42) and IRCSX (26.25) have equivalent 5 years return.
IRCSXMCISXIRCSX / MCISX
Total Expense Ratio1.332.1063%
Annual Report Gross Expense Ratio1.333.4938%
Fund Existence10 years19 years-
Gain YTD14.16013.473105%
Front LoadN/AN/A-
Min. Initial Investment50002500200%
Min. Initial Investment IRAN/AN/A-
Net Assets1.3B4.78B27%
Annual Yield % from dividends1.940.89219%
Returns for 1 year13.8026.7352%
Returns for 3 years53.7668.2079%
Returns for 5 years26.2526.4299%
Returns for 10 years75.20106.3371%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MENS2.160.10
+4.85%
Jyong Biotech Ltd
MWA25.080.41
+1.66%
Mueller Water Products
CPNG16.730.11
+0.66%
Coupang
WLKP23.270.09
+0.39%
Westlake Chemical Partners LP
ERNA8.07-1.04
-11.46%
Ernexa Therapeutics Inc.